4186 Share Price Performance
NT$14.95
-1.00 (-6.27%)
Price NT$14.95
Share PriceNT$14.95
Taiwan Advance Bio-Pharmaceutical Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
4186 Community Narratives
There are no narratives available yet.
Recent 4186 News & Updates
Taiwan Advance Bio-Pharmaceutical Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.26
- Gross Margin
- 67.58%
- Net Profit Margin
- 6.29%
- Debt/Equity Ratio
- 98.1%
Taiwan Advance Bio-Pharmaceutical Inc. Competitors
Snowflake Analysis
About 4186
- Founded
- 1989
- Employees
- 165
- CEO
- WebsiteView website
Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA, rapid, and chemical test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers abused drugs rapid tests; provides cell banking services for newborn and adult stem cells storage; and operates drug testing center for urine drug test, hair drug test, and identification of drug abuse. The company was founded in 1989 and is based in New Taipei City, Taiwan.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Taiwanese Market Performance
- 7 Days: 4.4%
- 3 Months: 18.9%
- 1 Year: 18.0%
- Year to Date: 16.2%
The market is up 4.4% over the last week, with the Information Technology sector leading the way, up 6.3%. As for the past 12 months, the market is up 18%. Earnings are forecast to grow by 18% annually. Market details ›